US-China Biomedical Technology Stock Forecast, Price & News

0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Today's Range
Now: $0.13
50-Day Range
MA: $0.19
52-Week Range
Now: $0.13
Volume20 shs
Average Volume1,100 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
US-China Biomedical Technology, Inc. operates as an early stage biomedical technology and services company. The company was formerly known as Cloud Security Corporation and changed its name to US-China Biomedical Technology, Inc. in February 2018. US-China Biomedical Technology, Inc. was founded in 2010 and is headquartered in Irvine, California.

Industry, Sector and Symbol

Industry Health Information Services
Current SymbolNASDAQ:UCBB
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Michael Schuman on US-China Relations (Radio)
March 21, 2021 |
See More Headlines


Overall MarketRank

0.34 out of 5 stars

Computer And Technology Sector

1339th out of 1,551 stocks

Health Information Services Industry

11th out of 15 stocks

Analyst Opinion: 0.0Community Rank: 1.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive UCBB News and Ratings via Email

Sign-up to receive the latest news and ratings for UCBB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

US-China Biomedical Technology (NASDAQ:UCBB) Frequently Asked Questions

What stocks does MarketBeat like better than US-China Biomedical Technology?

Wall Street analysts have given US-China Biomedical Technology a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but US-China Biomedical Technology wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has US-China Biomedical Technology's stock been impacted by COVID-19?

US-China Biomedical Technology's stock was trading at $0.0550 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, UCBB shares have increased by 129.1% and is now trading at $0.1260.
View which stocks have been most impacted by COVID-19

Who are US-China Biomedical Technology's key executives?

US-China Biomedical Technology's management team includes the following people:
  • Mr. Qingxi Huang, Chairman, CEO, Pres, CFO, Sec. & Treasurer (Age 48)
  • Ms. Jennifer Melton Johnson, Co-Founder
  • Mr. Brennan Johnson, Co-Founder

Who are some of US-China Biomedical Technology's key competitors?

What other stocks do shareholders of US-China Biomedical Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other US-China Biomedical Technology investors own include Towerstream (TWER), Energy Fuels (UUUU) and Bunker Hill Mining (BHLL).

What is US-China Biomedical Technology's stock symbol?

US-China Biomedical Technology trades on the NASDAQ under the ticker symbol "UCBB."

How do I buy shares of US-China Biomedical Technology?

Shares of UCBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is US-China Biomedical Technology's stock price today?

One share of UCBB stock can currently be purchased for approximately $0.13.

How many employees does US-China Biomedical Technology have?

US-China Biomedical Technology employs 3 workers across the globe.

What is US-China Biomedical Technology's official website?

The official website for US-China Biomedical Technology is

How can I contact US-China Biomedical Technology?

The company can be reached via phone at 949-679-3992.

This page was last updated on 4/17/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.